The U.S. Food and Drug Administration (FDA) has approved the infusion therapy Ocrevus (ocrelizumab) for treating children with relapsing-remitting multiple sclerosis (RRMS) who are ages 10 and older and weigh at least 55 pounds (25 kg). The approval makes Ocrevus the second-ever therapy to win formal FDA approval…
Discussion
More than 5,000 cyclists took part in the 2026 Bike MS: ACC Texas MS 150 event, a two-day fundraising ride with proceeds aiming to support research and services for people with multiple sclerosis (MS). Part of the Bike MS initiative, the Texas ride is the largest fundraising…
Discussion
Menstrual fluid collected from tampons could one day provide a simple, noninvasive way to measure a biomarker of nerve damage and potentially track disease activity in neurological conditions such as multiple sclerosis (MS). Researchers at Nextgen Jane, in collaboration with Siemens Healthineers…
Discussion
Between my tours with the Army, a new course was added to the curriculum for me to teach — a two-week basic combat skills course for support personnel. The logic was that if a mechanic or cook attached to a special forces team overseas ever had to do something outside…
Discussion
The first participant has been dosed in an investigator-initiated Phase 2 clinical trial testing Neuraly‘s experimental medication pegsebrenatide as a potential treatment for progressive forms of multiple sclerosis (MS). Called TAG-MS (NCT07497399), the study is being led by Ellen Mowry, MD, at…
Get regular updates to your inbox.
